Filed with the SEC on · accession 0001193125-26-454423
SRRK filed a 8-K (current report) with the SEC on Nov 10, 2026. Scholar Rock Inc., a wholly owned subsidiary of Scholar Rock Holding Corporation, entered into an asset purchase agreement to sell a Rare Pediatric Disease Priority Review Voucher (PRV) to BioNTech US Inc. for $205 million in cash.
Scholar Rock Inc., a wholly owned subsidiary of Scholar Rock Holding Corporation, entered into an asset purchase agreement to sell a Rare Pediatric Disease Priority Review Voucher (PRV) to BioNTech US Inc. for $205 million in cash. The PRV was awarded by the FDA on September 11, 2026, in connection with the approval of ISEMBYLD (apitegromab-mstn).
✦ Ask GOAX AI about this filing — what it means for SRRK, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for SRRK?
Click hereSRRK filed a 8-K (Divestiture). Scholar Rock Inc., a wholly owned subsidiary of Scholar Rock Holding Corporation, entered into an asset purchase agreement to sell a Rare Pediatric Disease Priority Review Voucher (PRV) to BioNTech US Inc. for $205 million in cash. The PRV was awarded by the FDA on September 11, 2026, in connection with the approval of ISEMBYLD (apitegromab-mstn).
A contract important enough that investors need to know about it — a big customer contract, a loan, a merger agreement or a partnership.
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
Get alerts when SRRK files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days